Blood-Clot Mimicking Patch to Deliver Drugs with Control
Researchers at the Midwest Cancer Nanotechnology Training Center (M-CNTC) are developing a blood-clot mimicking patch capable of delivering therapeutic drugs at an implantation site in a controllable manner. The patch, consisting of drug-releasing microparticles bound to directionally aligned microfibers, was formed through a unique electrospinning/electrospraying process. This image shows the 2-6 micrometer thick drug-releasing microparticles attached to the 1 micrometer thick directionally aligned microfibers on the patch.
This image is part of the Nanotechnology Image Library collection.
Credit: Ross DeVolde and Hyunjoon Kong, Ph.D., M.S., National Cancer Institute, National Institutes of Health
Blood-Clot Mimicking Patch to Deliver Drugs with Control
Researchers at the Midwest Cancer Nanotechnology Training Center (M-CNTC) are developing a blood-clot mimicking patch capable of delivering therapeutic drugs at an implantation site in a controllable manner. The patch, consisting of drug-releasing microparticles bound to directionally aligned microfibers, was formed through a unique electrospinning/electrospraying process. This image shows the 2-6 micrometer thick drug-releasing microparticles attached to the 1 micrometer thick directionally aligned microfibers on the patch.
This image is part of the Nanotechnology Image Library collection.
Credit: Ross DeVolde and Hyunjoon Kong, Ph.D., M.S., National Cancer Institute, National Institutes of Health